Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2003
10/23/2003WO2002099099A3 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications
10/23/2003WO2002092015A3 Reagents and methods for modulating dkk-mediated interactions
10/23/2003WO2002083723A3 Polypeptides from h. influenzae homologous to a surface-exposed protein of neisseria meningitidis
10/23/2003WO2002083708A3 Selective covalent-binding compounds having therapeutic diagnostic and analytical applications
10/23/2003WO2002081745A3 Genes involved in osteogenesis, and methods of use
10/23/2003WO2002077216A3 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby
10/23/2003WO2002077197A3 Methods for diagnosing and monitoring malignancies by screening gene copy numbers
10/23/2003WO2002070556A9 POLYPEPTIDE OF A P53 PROTEIN-SPECIFIC MURINE Α/β T-CELL RECEPTOR, NUCLEIC ACIDS CODING THEREFOR AND USE THEREOF
10/23/2003WO2002062380A3 Chlamydia vaccine composition
10/23/2003WO2002047720A3 Treatment and prevention of ebv infection and ebv-associated disorders
10/23/2003WO2002046384A3 Kinases and phosphatases sequences, and use thereof
10/23/2003WO2002044336B1 Method of making a protein polymer and uses of the polymer
10/23/2003WO2002036806A3 Expression vectors able to elicit improved immune response and methods of using same
10/23/2003WO2002036617A3 A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine
10/23/2003WO2001096376A9 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
10/23/2003WO2001005427A8 Psca: prostate stem cell antigen and uses thereof
10/23/2003US20030199679 Recombinant antibodies specific for TNF-alpha
10/23/2003US20030199676 Effective for proteins expressed in bacteria as inclusion bodies
10/23/2003US20030199675 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199673 For inducing immune response and administering immunotherapy
10/23/2003US20030199470 Determining the status of 158P1D7 gene products expressed by cells in a tissue sample; comparing the status so determined to the status of 158P1D7 gene products in normal sample; identifying the presence of aberrant 158P1D7 gene products
10/23/2003US20030199466 For modulating an immune response
10/23/2003US20030199464 Regeneration of endogenous myocardial tissue by induction of neovascularization
10/23/2003US20030199463 For therapy of cardiovascular disease, fibrotic disease
10/23/2003US20030199452 Antigenic peptides reacting with anti-ovary antibodies
10/23/2003US20030199438 Method for identification of proteins from intracellular bacteria
10/23/2003US20030199437 Identification, isolation and recombinant production of novel DNA; vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules; fused heterologous polypeptide sequences, binding antibodies; anticarcinogenic
10/23/2003US20030199435 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199427 Increased or improved bioavailability of the active agent
10/23/2003US20030199423 ICAM-related protein
10/23/2003US20030199103 Novel amino acid sequences for human epidermal growth factor-like polypeptides
10/23/2003US20030199074 Cold-adapted equine influenza viruses
10/23/2003US20030199043 Therapeutic proteins (including polypeptide, antibody, peptide or fragment or variants)fused to albumin or fragment or variant linked by a linker peptide; nonglycosylated
10/23/2003US20030199042 Novel morphogenic protein
10/23/2003US20030199013 A preferred synthetic polypeptide having at least one antigenic site of a prion protein which only exist in nervous tissue of a mammal suffering from spongiform encephalopathy
10/23/2003US20030199012 A nucleic acid construct having a nucleic acid molecule that encodes a factor suppressing an immune response to Mycobacterium tuberculosis in a host cell
10/23/2003US20030198994 Identification and isolation of novel DNA and the recombinant production of novel polypeptides encoded by that DNA
10/23/2003US20030198993 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030198986 Differential screening of a rat hippocampus cDNA library; a cDNA species encoding a novel protein designated Hct-1 is shown to be related to cytochromes P450
10/23/2003US20030198975 Proteins associated with cell growth, differentiation, and death
10/23/2003US20030198953 For diagnosis, treatment, and prevention of related disorders
10/23/2003US20030198951 Novel methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators
10/23/2003US20030198949 Viral polypeptides that regulate or modulate apoptosis
10/23/2003US20030198947 Hepatitis virus sentinel virus I (SVI)
10/23/2003US20030198946 Hepatitis-C virus testing
10/23/2003US20030198941 Method for making an HIV vaccine
10/23/2003US20030198939 In vitro culturing of monocytes in presence of monoclonal antibody
10/23/2003US20030198681 Method of making a protein polymer and uses of the polymer
10/23/2003US20030198678 Polynucleotide immobilized with block polyether polymer; antibodies against genetic disorders
10/23/2003US20030198651 Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein
10/23/2003US20030198650 Equine herpes viruses; hybrid nucleic acid
10/23/2003US20030198649 HBV core antigen particles with multiple immunogenic components attached via peptide ligands
10/23/2003US20030198647 Rheumatic diseases; autoimmune disease
10/23/2003US20030198645 Stabilized HBc chimer particles as therapeutic vaccine for chronic hepatitis
10/23/2003US20030198644 HCV peptide antigens and methods for the determination of HCV
10/23/2003US20030198643 Adjuvant enhanced immunotherapy
10/23/2003US20030198642 Vaccine vehicle; induce immunology response; anticancer agents
10/23/2003US20030198637 Antiproliferative agent; induction apoptosis; antitumor agents
10/23/2003US20030198636 Prevent completitive binding; amplification inflammation response; convertase inhibitor; side effect reduction
10/23/2003US20030198635 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms
10/23/2003US20030198633 Complexing antigen to antibodies
10/23/2003US20030198626 Induction gene expression in cells of major histocompatibility complex; antitumor agents
10/23/2003US20030198623 Attenuation Dna; coding cytokines, tumor antigen
10/23/2003US20030198622 vaccine including a polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy
10/23/2003US20030198621 Polynucleotides encoding antigenic HIV type B and/or type C polypeptides, polypeptides and uses thereof
10/23/2003US20030198617 Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof
10/23/2003US20030198601 Dry powder drug; aerosol administering
10/23/2003CA2849556A1 Preservation of bioactive materials by freeze dried foam
10/23/2003CA2483820A1 Production of haematophagous organisms and parasites suitable for vaccine production
10/23/2003CA2482926A1 Modified factor viii
10/23/2003CA2482718A1 Derivatives of the il-2 receptor gamma chain, their production and use
10/23/2003CA2482634A1 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction
10/23/2003CA2482448A1 Preservation of bioactive materials by freeze dried foam
10/23/2003CA2482387A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003CA2482244A1 Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis
10/23/2003CA2481980A1 Particle-bound human immunodeficiency virus envelope glycoproteins and related compositions and methods
10/23/2003CA2481796A1 Binding agents and their use in targeting tumor cells
10/23/2003CA2481752A1 Composition for modulating a physiological reaction or inducing an immune response
10/23/2003CA2481747A1 Recombinant anti-interleukin-9 antibodies
10/23/2003CA2481515A1 Anti-her2 antibody variants
10/23/2003CA2481508A1 G-protein coupled receptor ligands and methods
10/23/2003CA2481503A1 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
10/23/2003CA2481462A1 Heteroclitic analogs and related methods
10/23/2003CA2481207A1 Methods of treatment using ctla-4 antibodies
10/23/2003CA2481186A1 Attenuated gram negative bacteria
10/23/2003CA2481087A1 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
10/23/2003CA2481074A1 Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors
10/23/2003CA2481042A1 Mycoplasma polypeptides
10/23/2003CA2480879A1 Tyrosine kinase inhibitors
10/23/2003CA2480775A1 Immunostimulatory g,u-containing oligoribonucleotides
10/23/2003CA2480758A1 Tyrosine kinase inhibitors
10/23/2003CA2480745A1 Methods for treating tweak-related conditions
10/23/2003CA2480079A1 Antiangiogenic active immunotherapy
10/23/2003CA2479835A1 An ephrin-b receptor protein involved in carcinoma
10/22/2003EP1355152A1 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen
10/22/2003EP1355025A2 Anti-panic opening system for doors
10/22/2003EP1354961A1 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene
10/22/2003EP1354953A1 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/22/2003EP1354950A1 Nf-kb activating gene
10/22/2003EP1354895A1 Neopeptides useful for detection and treatment of cancer
1 ... 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 ... 1823